| Trial ID: | L0919 |
| Source ID: | NCT01198379
|
| Associated Drug: |
Aspirin
|
| Title: |
Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease
|
| Interventions: |
DRUG: aspirin|DRUG: Placebo
|
| Outcome Measures: |
Primary: the prevalence of aspirin resistance, 3 years | Secondary: the incidence of vascular events (myocardial infarction, cardiac death, stroke, vascular access thrombosis, or revascularization procedure), 3 years
|
| Sponsor/Collaborators: |
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | Collaborators: Taipei Veterans General Hospital, Taiwan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-02
|
| Completion Date: |
2018-01-15
|
| Results First Posted: |
|
| Last Update Posted: |
2019-01-17
|
| Locations: |
Taipei Veterans General Hospital, Taipei, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT01198379
|
